LCE6A inhibitors are chemical compounds that specifically target and modulate the activity of the LCE6A protein, a member of the late cornified envelope (LCE) family. This family of proteins plays a crucial role in the formation of the epidermal barrier, particularly during the differentiation of keratinocytes in the outermost layer of the skin. LCE6A, like other LCE proteins, contributes to the assembly of the cornified envelope, which is essential for maintaining the integrity and function of the skin barrier. Inhibitors of LCE6A typically act by interfering with its function, possibly by binding to active sites or altering the protein's ability to interact with other components involved in the cornification process.
These inhibitors are often developed using high-throughput screening techniques to identify molecules that can selectively bind to the LCE6A protein. The development of these compounds relies heavily on understanding the structure of LCE6A, including its interaction domains and conformational changes. By inhibiting the function of LCE6A, these compounds provide valuable tools for studying the physiological processes underlying skin barrier formation and keratinocyte differentiation. Researchers use LCE6A inhibitors to explore the protein's role in various cellular pathways and to investigate the molecular mechanisms by which the cornified envelope is assembled and maintained. Through these studies, the detailed biochemical and structural properties of LCE6A can be elucidated, contributing to a broader understanding of skin biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Promotes keratinocyte differentiation and may influence the expression of LCE6A as part of the skin's adaptive response to retinoids. | ||||||
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $199.00 $816.00 | 4 | |
A vitamin D3 analog that modulates keratinocyte proliferation and differentiation, potentially affecting LCE6A expression. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $100.00 | 6 | |
Used for their anti-inflammatory properties, potentially affecting skin barrier proteins including LCE6A by modulating keratinocyte function. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $76.00 $148.00 | 9 | |
An immunosuppressant applied topically for skin conditions, potentially influencing LCE6A expression through effects on skin inflammation and repair mechanisms. | ||||||
Pimecrolimus | 137071-32-0 | sc-208172 | 1 mg | $140.00 | 2 | |
Similar to tacrolimus, used for skin conditions with potential indirect effects on LCE6A through modulation of skin repair and barrier function. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant known to influence skin barrier function, possibly affecting LCE6A expression indirectly. | ||||||
Glycolic acid solution | 79-14-1 | sc-215102 sc-215102A | 25 g 500 g | $38.00 $60.00 | ||
An alpha-hydroxy acid that influences skin turnover and barrier function, potentially affecting LCE6A expression. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $46.00 $92.00 $117.00 | 3 | |
A beta-hydroxy acid with keratolytic properties, which could indirectly impact LCE6A levels by promoting exfoliation and influencing skin barrier proteins. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $43.00 $65.00 $200.00 $815.00 | 6 | |
Vitamin B3 with anti-inflammatory properties, potentially influencing LCE6A expression by enhancing skin barrier function. | ||||||
Urea | 57-13-6 | sc-29114 sc-29114A sc-29114B | 1 kg 2 kg 5 kg | $30.00 $42.00 $76.00 | 17 | |
Acts as a humectant and keratolytic, potentially influencing skin hydration and barrier function, thereby possibly affecting LCE6A expression. | ||||||